Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.44 EPS, expectations were $-0.49.
Source: insidermonkey.com
Page 12 - John Jacobs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Jacobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Jacobs Today - Breaking & Trending Today
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript February 28, 2024 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.44 EPS, expectations were $-0.49. NVAX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to Novavax […]
Source: yahoo.com
Novavax sees 2024 sales flat to lower, aims to pick up COVID vaccine market share
COVID-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial performance and pick up market share from much larger rivals,...
Source: marketscreener.com
Novavax Profit, Sales Fall in 4Q
By Emon Reiser Novavax reduced its losses in the fourth quarter as the company cut its headcount. The Gaithersburg, Md.-based vaccine maker posted a loss of...
Source: marketwatch.com
Novavax (NVAX) earnings report Q4 2023
Novavax narrowed its losses in the quarter compared to the same period a year ago, even as demand for Covid products continues to plummet worldwide.
Source: cnbc.com